These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35322566)

  • 1. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
    Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
    Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
    Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement deposition on renal histopathology of patients with diabetic nephropathy.
    Sun ZJ; Li XQ; Chang DY; Wang SX; Liu G; Chen M; Zhao MH
    Diabetes Metab; 2019 Sep; 45(4):363-368. PubMed ID: 30243617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.
    Duan S; Sun L; Zhang C; Wu L; Nie G; Huang Z; Xing C; Zhang B; Yuan Y
    Int Immunopharmacol; 2021 Apr; 93():107413. PubMed ID: 33524800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Impact of Glomerular Immunoglobulin M Deposition in Patients with Type 2 Diabetic Nephropathy.
    Tang X; Li H; Li L; Zhang J; Xu H; Li L; Liu F
    Am J Med Sci; 2018 Oct; 356(4):365-373. PubMed ID: 30360805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological characteristics of DKD patients with early-onset type 2 diabetes.
    Wu L; Zhao YY; Li MR; Chang DY; Zhao MH; Chen M
    J Diabetes Complications; 2023 Aug; 37(8):108520. PubMed ID: 37311359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
    J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
    Diabetes Res Clin Pract; 2018 Jul; 141():1-9. PubMed ID: 29684616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease.
    Lee YH; Seo JW; Kim M; Tae D; Seok J; Kim YG; Lee SH; Kim JS; Hwang HS; Jeong KH; Moon JY
    Front Endocrinol (Lausanne); 2021; 12():774436. PubMed ID: 34858345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
    Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
    Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.
    Yamanouchi M; Mori M; Hoshino J; Kinowaki K; Fujii T; Ohashi K; Furuichi K; Wada T; Ubara Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000726. PubMed ID: 31798893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy.
    Zhang J; Wang Y; Gurung P; Wang T; Li L; Zhang R; Li H; Guo R; Han Q; Zhang J; Lei S; Liu F
    Acta Diabetol; 2018 Jul; 55(7):669-679. PubMed ID: 29610978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.